FindTrial
Sign In

Comparative Evaluation of EUS-guided hepaticogastrostomy (EUS-HGS) and EUS guided antegrade technique (EUS-AG) in patients with malignant biliary obstructive: a multicenter randomized controlled trial

Comparative Evaluation of EUS-guided hepaticogastrostomy (EUS-HGS) and EUS guided antegrade technique (EUS-AG) in patients with malignant biliary obstructive: a multicenter randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020737
Enrollment
Unknown
Registered
2019-01-15
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant biliary obstruction

Interventions

HGS:EUS-guided hepaticogastrostomy
AG group:EUS-guided antegrade technique

Sponsors

Shenjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients with unresectable malignant biliary obstruction undergoing: 1) failed ERCP; 2) anatomical abnormalities; 3) low-level biliary obstruction and pyloric or duodenal obstruction caused by tumors

Exclusion criteria

Exclusion criteria: Patients with a clear contraindication to endoscopy.

Design outcomes

Primary

MeasureTime frame
Success rate of operation technology;Clinical remission rate;—

Secondary

MeasureTime frame
Incidence of complications;hospital stay;Average hospitalization cost;—

Countries

Japan

Contacts

Public ContactGuo Jintao

Shenjing Hospital of China Medical University

guojt@sj-hospital.org+86 18940256654

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026